Syngene and Baxter International have collaborated to establish the Baxter Global Research Centre at Syngene, in Bangalore. The centre was inaugurated by Ghulam Nabi Azad, Minister of Health and Family Welfare, Government of India, in the presence of UT Khader, Minister of Health & Family Welfare, Government of Karnataka, SR Patil, Minister of IT,BT and ST, Government of Karnataka, Keshav Desiraju, Secretary, Department of Health & Family Welfare, Government of India and Srivatsa Krishna, Secretary, Department of IT, BT and ST, Government of Karnataka.
The Baxter Global Research Centre (BGRC) at Syngene, is a part of Baxter’s global strategy of building R&D collaborations with strategic partners. This collaboration will support Baxter in the research and development of medical products and devices to serve patients both in India and around the world.
A team of over 100 multi-disciplinary Syngene scientists will be based at this dedicated centre of excellence at Syngene in Biocon Park, Bangalore. The Syngene team, working closely with Baxter scientists, will engage in a wide range of R&D activities centered on product and analytical development and pre-clinical evaluation in parenteral nutrition and renal therapy.
Speaking at the inauguration, Jean-Luc Butel, Corporate Vice President and President- International, Baxter, said, “Baxter is pleased to be part of the opening of this Syngene facility dedicated to providing Baxter with technical and scientific capabilities that will augment our own internal resources. Baxter is committed to helping save and sustain patients’ lives worldwide, and innovation is the driver of success in this area.”
Kiran Mazumdar Shaw, Chairperson, Biocon, said, “Biocon is pleased to partner with Baxter through its research services arm, Syngene. We share a common vision with Baxter, focused on developing pharmaceutical products that advance patient care worldwide and this new research centre will be a significant step towards enabling that objective.”
Commenting on the collaboration, Peter Bains, Director, Syngene International, said, “We are proud and excited to be collaborating with Baxter in establishing the Baxter Global Research Centre at Syngene in India. The scale and scope of activities signal the strategic nature of the collaboration and also reflect Syngene’s capabilities to offer broad based complimentary integrated development services. We look forward to working closely with Baxter’s scientists to support advancing their R&D goals.”
The rising incidence of chronic diseases like diabetes, cancer, cardiovascular and renal diseases pose an enormous challenge and disease burden for the various healthcare systems around the world. There is a compelling need to intensify R&D efforts for developing novel therapeutics and diagnostic capabilities that enable various governments meet the challenges of affordability and access to treatment. Syngene and Baxter’s collaboration is aimed at making a contribution to this greater cause.
EP News Bureau – Mumbai
- Advertisement -
